Carsten Thiel: Leadership In Medicine With An Impact

 

Carsten Thiel was born in Berlin, Germany and lived there throughout his youth. He went to the University of Bristol in the Southwest of the UK, where he got a Bachelor of science, after which he began to study, biochemistry. He then attended the Max Planck Institute for Biophysical Chemistry, where he earned a Ph.D. in molecular biology, where his project was to study the changes in healthy cells as to why they become a cancerous cell. He gained a position at Hoffman La-Roche, an innovative biotech firm. Thiel’s specific involvement in making medical breakthrough therapies has improved the lives of many a patient.

 

An article from IdeaMensch entitled: “Carsten Thiel: Pharmaceutical & Biopharmaceutical Expert”, Thiel shared how he started his foray into the innovative realm of pharmaceuticals and further expressed his views about the “Golden Age of Biotechnology”.

 

He started off as a Communications and Product Manager at Hoffman La-Roche. Thiel’s work ethic involves giving good customer service. Carsten Thiel has also been the former General Manager of Insadong Eastern Europe, having had years of experience with successful product launchings. Thiel has a strong code of ethics where he has proven to be a prominent leader in the workplace.

 

Carsten Thiel uses a calendar although he may wind up with too many commitments in one busy day sometimes. He spends 20%-25% of his day with the board of the company. Carsten Thiel bring ideas to life means that he tries to use his leeway to bring together a cooperative effort. He feels that technology keeps being invented and we are keeping up with the new inventions.

 

Things that were previously not thought possible are becoming possible, such as decoding the human genome now takes four days. In the future, it could be cut down to an hour or less to do so. We are looking for ways to treat illness or outright disabilities because people in future generations will see this as a progressive time. Great success has been found at his company. Read This Article to learn more.

 

Like him on https://www.facebook.com/carsten.thiel.58

 

Carsten Thiel: Patient-First Medical Approach

 

Carsten Thiel is the Chief Executive Officer of Abeona Therapeutics. This is a leading gene and cell therapy organization. Carsten is a renowned individual in the field of biotechnology. Throughout his journey, he has gained experience and leadership skills that have enabled him to launch some great medical products. Some of these medical therapy products include Vectibix, Prolia and Strensiq.

He has used these products to not only offer therapy but also change the lives of many patients all over the world. Carsten Thiel uses medical ethics to make his decisions and is convinced that going against the established medical etiquettes can be used to provide a more favorable relationship with the patients.

Carsten started his career in at Hoffman La-Roche, a leading biotechnology firm is forward thinking in the innovation of pharmaceuticals. Here, he learned and improved his innovative, scientific and interpersonal skills. He was later made responsible in the sector of scientific thinking and account management. He learned a lot and maintained integrity in the sector before landing into the responsibility of launching Xenical, a weight loss product. Carsten chose a marketing strategy that had the customers’ needs in the long run, unlike other products that saw a great increase in sales.

Focusing on the patient became a key aspect of innovation for Carsten. He adopted the method of training customers, providers and involved parties before therapy. The method was costly at first but the results were remarkable in the end and the method became the best of all tested. Carsten holds empathy and compassion as the key to launching a successful medical product.

His commitment to helping people made him look for alternative waysh to assist patients to get treatment successfully. Using technology, Carsten Thiel has also implemented the provision of therapy to patients in the comfort of their homes in a creative and humane way. See Related Link for additional information.

 

Source article: https://globenewswire.com/news-release/2018/04/02/1458445/0/en/Abeona-Therapeutics-Appoints-Carsten-Thiel-Ph-D-as-Chief-Executive-Officer.html

Carsten Thiel On Why Biotechnology Is Now Peaking

 

Industries have a way of ebbing and flowing over time. Many of us don’t necessarily notice this unless they directly impact us, but they do matter for the broader economy and indeed for the entire human race as a whole. Carsten Thiel believes that right now we are seeing a boom in the biotechnology space that will help us create and invent amazing things that we could scarcely imagine before.

Carsten Thiel is an authority in biotechnology having spent a good number of years in the industry. He believes that the field has entered its golden age and the future holds a lot of promise. Answers to pertinent human concerns like living disease-free lives are sure to be addressed during this period.

Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening. It is a company that is a major part of the golden age of biotechnology that Carsten Thiel is very much a part of.

Biotechnology Is Now More Affordable

It doesn’t take a math whiz to tell you that as something becomes more affordable more people will take part in it. We live on a planet of limited resources and we have to use those resources wisely. Advances in biotechnology in recent years have made it more cost effective than ever to expand our abilities to make those leaps and to generate real results that impact the way that people live their lives. Refer to This Article to learn more.

Investors Are Waiting To Jump In

Plenty of investors are waiting to jump into a space like this just as soon as they believe that it is financially viable for them to do so. Many investors have seen what is going on currently and certainly believe that now is the time to get in. They understand that all people will gain something from the inventions that the biotechnology space is able to create so they are eager and pleased to jump right in. As this continues to happen it will propel even more investment and even more advancements in a cycle that will help us all.

 

View source article: https://www.marketscreener.com/business-leaders/F-Carsten-Thiel-07CNZG-E/biography/

 

“Marc Beer is Pioneering in Solving Pelvic Floor Disorders “

A considerable number of investors around the world have been investing in various companies with the sole aim of generating income that they can either reinvest or use in other personal activities. Some of the major investors around the world are channeling their resources in the information communication sector. However, one investor is going a different direction, which might have looked misinformed at the beginning but is now a strategic decision that is attracting positive reviews around the world.

 

Marc Beer co-founded Renovia Inc., a technology-based medical company that is focused explicitly on solving women’s health. Current studies show that health is an issue of concern in the United States. Recent reports indicate that a huge number of people have been looking for medical services and support from various medical facilities around the country. Other people have been spending huge amounts of money to try and solve their health issues, but there are no clear reports that they have been getting the services they want.

 

Renovia Inc. is one of the few medical companies that have targeted a niche that has for a long period been neglected by a huge number of individuals around the world. Both state and Federal Government concentrate on medical funding schemes that provide general medical services to individuals, but they don’t focus on ensuring that the specific needs of particular patients have been addressed. This explains why women with unique medical conditions have never accessed the services they would have wanted.

 

Renovia Inc. is specializing in women health by ensuring that there is the necessary technology that can be used in providing a solution to most of the illnesses that affect women. Noteworthy, Renovia Inc. is only focused on helping women to solve pelvic floor disorders, which has, for a longer period, been a cause for death and severe diseases among women. One of the diseases that are associated with pelvic floor disorders is Urinary tract infection, which is currently affecting a huge number of people around the world.

 

Recent studies show that more than two hundred million women have been diagnosed with pelvic floor disorders. The number could be huge because these data were only collated from developed countries. It is evident that developing countries have their share of women with urinary tract infections.

 

Marc Beer

 

Marc Beer is the idea behind Renovia Inc., which is a clear indication that he is focused on eliminating women-specific diseases around the world. He is an experienced medical expert who has been in the pharmaceutical industry for more than twenty-five years. Many people know Marc Beer as a commercial expert in the pharmaceutical sector, which means that he clearly understands how to bring funds on the table and propel the growth of a pharmaceutical company. Learn more: https://renoviainc.com/

 

How Carsten Thiel And Others Work For The Future Of Biotechnology

 

We are now at what we call the Golden Age of Biotechnology. This era holds the answers to a healthier life, disease-free communities, and living longer.

Each of the industry in today’s economy presents a moment in which their technological innovations accelerate in an exponential fashion. This form of acceleration is due to three revolutions:

The speed of technological advancement

In 1995, the sequencing of the first genome costs around $2.7 billion. In 2008, this cost decreased to about $10 million. Today, this cost is now at $1,000. With automation, the speed, efficiency, as well as cost, brings about new inventions to the market; all of which presents a dramatic impact to biotechnology.

A better grasp at the concept of human biology

With these speedy technological advancements, we are now provided with better opportunities to understand and manipulate human biology. Cellular biology findings lead us to new disease targets which paved the way to the development of drugs like proton pump antagonists, histamine receptor antagonists, and statins and ACE inhibitors.

A major modality revolution

Modality revolution started in the early 1980s and 1990s. Therapeutic proteins for the purpose of targeting diseases were made possible. Today, a great number of modalities can now be engineered as tools to interdict biological targets. Carsten Thiel, among others, presents regenerative cell therapies, gene therapy, nanoparticle delivery systems, and so much more.

Carsten Thiel is an authority in biotechnology having spent a good number of years in the industry. He believes that the field has entered its golden age and the future holds a lot of promise. Answers to pertinent human concerns like living disease-free lives are sure to be addressed during this period.

Carsten Thiel has a Ph.D and was the CEO of Abeona Therapeutics Inc. This is a biopharmaceutical company for clinical-stages that mainly develops gene and cell therapies for genetic diseases that are rare and life-threatening. It is a company that is a major part of the golden age of biotechnology that Carsten Thiel is very much a part of.

Biotechnology is not the only industry that heavily contributes to this speedy acceleration. In fact, the field of medicine has also developed innovations which have paved the way to a faster and non-linear progression in understanding our era’s different diseases. Click Here to visit Thiel’s Linkedin profile.

 

Follow Carsten on https://twitter.com/fcthiel